The United States genetic testing market growth is anticipated to progress at a CAGR of 10.61% during the forecast period, 2022-2028, reaching a revenue of $8596.6 million by 2028.

There is increased adoption of genetic testing, given its vast applications in the healthcare sector. For instance, it covers chronic diseases like cancer, genetic diseases, and cardiovascular conditions. Also, with large healthcare expenditure, the growing population prefers such testing procedures. Besides, there is an increasing need and awareness about early and preventive care.

To know more about this report, request a free sample copy

In the United States, a steady increase in the insurance coverage of varied genetic tests by key insurance companies is a significant trend impacting the market growth. Also, the rising economic burden associated with disease treatment has led to governing bodies and healthcare providers increasingly prioritizing early screening and diagnosis for health risks.

Genetic tests are used for detecting serious medical problems and diseases. As a result, such tests have become an essential part of preventive care since most private healthcare players are incorporating them into the reimbursement policies. Besides, a large number of people are opting for such testing procedures for rare genetic disorders.

Furthermore, genomic and genetic testing are expanding across different medical specialties, resulting in strong testing volume managed by non-geneticists. Moreover, the technological advancements to enhance testing accuracy offer growth opportunities. Also, the US has economic advantages and increased funding with regard to research and production of innovative medical devices.

The United States genetic testing market report scope includes the segmentation assessment of application, disease, type, and technology. The type segment is further sub-categorized into Prenatal and newborn testing, diagnostic testing, predictive & presymptomatic testing, pharmacogenomic testing, carrier testing, and other types.

Carrier testing is evaluated to project promising growth during the forecast period. It is a genetic test for determining whether a person is a carrier of the recessive genetic disease. It is a disease caused due to mutation on both genes of a pair. As a result, if both parents are carriers, they have a 25% risk of having a child with recessive genetic disease. In addition, there is also a 50% risk that the child will be a carrier.

Further, diagnostic testing is expected to garner more revenue share during the forecast period. It is used to rule out or identify a specific chromosomal or genetic condition. At the same time, it is utilized to confirm a diagnosis when a certain condition is evaluated based on physical symptoms. It can be conducted before birth or any time during a person’s life but has limited coverage for genetic conditions. The results can be vital in early disease diagnosis and minimizing major health crises. Moreover, it can help patients implement informed decisions and incorporate lifestyle changes that can likely restrict the disease’s magnitude.

Some of the eminent market players in the United States genetic testing market include PerkinElmer Inc, Illumina Inc, Bio-Rad Laboratories, Myriad Genetics Inc, etc.

Illumina Inc offers array-based and sequencing solutions for genomic and genetic analysis. It markets and distributes its products directly to consumers in Asia-Pacific, Latin America, Europe, and North America. It also offers consumables and instruments used in genotyping & sequencing services, genetic analysis, development & licensing agreements, and instrument service contracts. It caters to academic institutions, genomic research centers, hospitals, government laboratories, consumer genomics companies, commercial molecular diagnostic laboratories, etc. It is headquartered in San Diego, California.

One of its key products, RNA prep enrichment, helps achieve rapid interrogation of an expansive number of target genes that include the RNA exome.

Report Synopsis

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.